Microbot Medical Inc (MBOT): Debts to Book Capitalization

Brandmark of Microbot Medical, Inc. (MBOT)

The price history of Microbot Medical Inc. (MBOT) shares on the GURU.Markets platform is 0.01. Microbot Medical Inc. (MBOT) operates in an autonomous cycle independent of global markets, establishing it as a defensive asset. The business develops intelligent systems for vascular surgeries with profit growth potential driven by the sale of consumables. Additionally, the company is implementing surgical microrobots, guaranteeing hospitals multi-year procurement of high-margin instruments.

MBOT (Microbot Medical, Inc) Debt to Book Value history from 07/04/2022 to 10/27/2026
Original product of Microbot Medical, Inc

This metric reflects the dynamics of the ratio of total liabilities to net asset value, capturing the sensitivity of the debt load to operating expenses and capital inflows. Amid the deployment of assembly lines and the integration of AI algorithms into Microbot Medical Inc. (MBOT) microcatheters, analyzing financial dependency levels based on balance sheet capital allows for an assessment of the risk of share devaluation resulting from excessive borrowing to scale the business.

Who Microbot Medical Inc. competes with

ISRG - Debts to Book Capitalization|Debt to Book Value Ratio danaher.com DHR|Debts to Book Capitalization BDX (Becton Dickinson)|STE - Debts to Net Assets|WST (West Pharmaceutical Services Inc) - Debts to Book Capitalization|Baxter Healthcare (BAX) - Debt to Book Value|MASI (Masimo Corporation) - Debts to Book Capitalization|Debts to Book Capitalization STVN|Debt to Book Capitalization Ratio Teleflex (TFX)|Debt to Book Capitalization Ratio Merit Medical Systems, Inc. MMSI|Debt to Book Value Envista Holdings Corp|Debt to Net Assets Ratio ICU Medical Inc. ICUI|Debts to Book Capitalization XRAY (DENTSPLY SIRONA Inc.)|LMAT: Debts to Net Assets|Debt to Book Capitalization Ratio AtriCure|STAA (STAAR Surgical Co.) - Debt to Book Value Ratio|NAGE: Debt to Book Capitalization Ratio|Debts to Net Assets ZimVie Corp (ZIMV)|Debt to Book Value AngioDynamics, Inc.|Debt to Book Capital CERS (cerus.com)|Debt to Book Capitalization Ratio Teknova|MGRM - Debt to Net Assets Ratio|Sharps Tech - Debt to Book Value|INFU: Debts to Book Capitalization|UTMD (Utah Medical Products) - Debt to Book Capitalization Ratio|KORU Medical (KRMD) - Debt to Book Value|Debts to Book Capitalization NYXH (Nyxoah)|Debts to Book Value PDEX|Debt to Book Capitalization Ratio Zentek Limited ZTEK|Debt to Book Value Ratio Elutia Corporation ELUT|Debt to Book Value Milestone Scientific (MLSS)|nexgel.com - Debt to Book Capital|Debt to Book Capitalization Ratio RVP (Retractable Tech)|HBIO: Debts to Net Assets|FEMY (Femasys Corp) - Debt to Book Capitalization Ratio|Meihua Medical Technologies Co., Ltd. (MHUA) - Debt to Book Value|POAI: Debts to Book Capitalization|Debts to Net Assets Callan JMB Corp|Debts to Book Capitalization ATRI (Atrion)|Debt to Book Value NURO (NeuroMetrix Inc)